Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis.
| Autor: | Bustany, Sophie1, Cahu, Julie1, Descamps, Géraldine2, Pellat-Deceunynck, Catherine2, Sola, Brigitte1 brigitte.sola@unicaen.fr |
|---|---|
| Zdroj: | Journal of Hematology & Oncology. 2015, Vol. 8 Issue 1, p1-4. 4p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|